Bicycle Therapeutics plc (BCYC) Misses Q2 EPS by 6c

Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q2 EPS of ($0.90), $0.06 worse than the analyst estimate of ($0.84). Revenue for the quarter came in at $4.38 million versus the consensus estimate of $3.69 million.

For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery